Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection

Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplant immunology 2009-07, Vol.21 (3), p.140-142
Hauptverfasser: Sarri, Stephanie, Shaw, Steven M, Gieschen-Krische, Mary A, Archer, Louise, Yonan, Nizar, Fildes, James E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue 3
container_start_page 140
container_title Transplant immunology
container_volume 21
creator Sarri, Stephanie
Shaw, Steven M
Gieschen-Krische, Mary A
Archer, Louise
Yonan, Nizar
Fildes, James E
description Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.
doi_str_mv 10.1016/j.trim.2009.04.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_864962092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0966327409000379</els_id><sourcerecordid>67332058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</originalsourceid><addsrcrecordid>eNp9kc2KFDEYRYMoTs_oC7iQrHRVZf4qPyDCMOgojLhQd0JIp77MpKa60iZVar-9KbpBcDGr8MG5l3AuQi8oaSmh8s3QzjnuWkaIaYloCWGP0IZqpZtOGPYYbYiRsuFMiTN0XspAKtEZ9RSdUcO1ZJpu0I_Ph-Rd7qMb8R24GZe75O_xPqcZ4oQlwfBnn6GUmCYcC17qcbuMboYehzSO6XecbrHzywz42ONxhgH8XAPP0JPgxgLPT-8F-v7h_berj83Nl-tPV5c3jReCzs2Wu9AHYyhVnaIqEKe4NooxsaVbKUD4YLzXTGofRN9R55TnIvTeMNWBEfwCvT721m__XKDMdheLh3F0E6SlWC2FkYwYVslXD5JScc5IpyvIjqDPqZQMwe6ra5cPlhK72reDXe3b1b4lwla3NfTy1L5sd9D_i5x0V-DtEYBq41eEbIuPMHnoY67KbJ_iw_3v_ov7MU7Ru_EeDlCGtOSperbUFmaJ_bruv85PTJ2eK8P_Atr2q70</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67332058</pqid></control><display><type>article</type><title>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sarri, Stephanie ; Shaw, Steven M ; Gieschen-Krische, Mary A ; Archer, Louise ; Yonan, Nizar ; Fildes, James E</creator><creatorcontrib>Sarri, Stephanie ; Shaw, Steven M ; Gieschen-Krische, Mary A ; Archer, Louise ; Yonan, Nizar ; Fildes, James E</creatorcontrib><description>Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.</description><identifier>ISSN: 0966-3274</identifier><identifier>EISSN: 1878-5492</identifier><identifier>DOI: 10.1016/j.trim.2009.04.002</identifier><identifier>PMID: 19386281</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute cardiac rejection ; Allergy and Immunology ; Chaperonin 60 - biosynthesis ; Female ; Graft Rejection - drug therapy ; Graft Rejection - immunology ; Heart Transplantation - immunology ; Heat shock protein 60 ; Humans ; Immune system ; Immunosuppressive Agents - therapeutic use ; Male ; Middle Aged ; Myocardium - immunology ; Up-Regulation</subject><ispartof>Transplant immunology, 2009-07, Vol.21 (3), p.140-142</ispartof><rights>Elsevier B.V.</rights><rights>2009 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</citedby><cites>FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.trim.2009.04.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19386281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sarri, Stephanie</creatorcontrib><creatorcontrib>Shaw, Steven M</creatorcontrib><creatorcontrib>Gieschen-Krische, Mary A</creatorcontrib><creatorcontrib>Archer, Louise</creatorcontrib><creatorcontrib>Yonan, Nizar</creatorcontrib><creatorcontrib>Fildes, James E</creatorcontrib><title>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</title><title>Transplant immunology</title><addtitle>Transpl Immunol</addtitle><description>Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.</description><subject>Acute cardiac rejection</subject><subject>Allergy and Immunology</subject><subject>Chaperonin 60 - biosynthesis</subject><subject>Female</subject><subject>Graft Rejection - drug therapy</subject><subject>Graft Rejection - immunology</subject><subject>Heart Transplantation - immunology</subject><subject>Heat shock protein 60</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardium - immunology</subject><subject>Up-Regulation</subject><issn>0966-3274</issn><issn>1878-5492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEYRYMoTs_oC7iQrHRVZf4qPyDCMOgojLhQd0JIp77MpKa60iZVar-9KbpBcDGr8MG5l3AuQi8oaSmh8s3QzjnuWkaIaYloCWGP0IZqpZtOGPYYbYiRsuFMiTN0XspAKtEZ9RSdUcO1ZJpu0I_Ph-Rd7qMb8R24GZe75O_xPqcZ4oQlwfBnn6GUmCYcC17qcbuMboYehzSO6XecbrHzywz42ONxhgH8XAPP0JPgxgLPT-8F-v7h_berj83Nl-tPV5c3jReCzs2Wu9AHYyhVnaIqEKe4NooxsaVbKUD4YLzXTGofRN9R55TnIvTeMNWBEfwCvT721m__XKDMdheLh3F0E6SlWC2FkYwYVslXD5JScc5IpyvIjqDPqZQMwe6ra5cPlhK72reDXe3b1b4lwla3NfTy1L5sd9D_i5x0V-DtEYBq41eEbIuPMHnoY67KbJ_iw_3v_ov7MU7Ru_EeDlCGtOSperbUFmaJ_bruv85PTJ2eK8P_Atr2q70</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Sarri, Stephanie</creator><creator>Shaw, Steven M</creator><creator>Gieschen-Krische, Mary A</creator><creator>Archer, Louise</creator><creator>Yonan, Nizar</creator><creator>Fildes, James E</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20090701</creationdate><title>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</title><author>Sarri, Stephanie ; Shaw, Steven M ; Gieschen-Krische, Mary A ; Archer, Louise ; Yonan, Nizar ; Fildes, James E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acute cardiac rejection</topic><topic>Allergy and Immunology</topic><topic>Chaperonin 60 - biosynthesis</topic><topic>Female</topic><topic>Graft Rejection - drug therapy</topic><topic>Graft Rejection - immunology</topic><topic>Heart Transplantation - immunology</topic><topic>Heat shock protein 60</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardium - immunology</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarri, Stephanie</creatorcontrib><creatorcontrib>Shaw, Steven M</creatorcontrib><creatorcontrib>Gieschen-Krische, Mary A</creatorcontrib><creatorcontrib>Archer, Louise</creatorcontrib><creatorcontrib>Yonan, Nizar</creatorcontrib><creatorcontrib>Fildes, James E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Transplant immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarri, Stephanie</au><au>Shaw, Steven M</au><au>Gieschen-Krische, Mary A</au><au>Archer, Louise</au><au>Yonan, Nizar</au><au>Fildes, James E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</atitle><jtitle>Transplant immunology</jtitle><addtitle>Transpl Immunol</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>21</volume><issue>3</issue><spage>140</spage><epage>142</epage><pages>140-142</pages><issn>0966-3274</issn><eissn>1878-5492</eissn><abstract>Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>19386281</pmid><doi>10.1016/j.trim.2009.04.002</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0966-3274
ispartof Transplant immunology, 2009-07, Vol.21 (3), p.140-142
issn 0966-3274
1878-5492
language eng
recordid cdi_proquest_miscellaneous_864962092
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Acute cardiac rejection
Allergy and Immunology
Chaperonin 60 - biosynthesis
Female
Graft Rejection - drug therapy
Graft Rejection - immunology
Heart Transplantation - immunology
Heat shock protein 60
Humans
Immune system
Immunosuppressive Agents - therapeutic use
Male
Middle Aged
Myocardium - immunology
Up-Regulation
title Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A49%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myocardial%20heat%20shock%20protein%2060%20expression%20is%20upregulated%20following%20acute%20cardiac%20rejection&rft.jtitle=Transplant%20immunology&rft.au=Sarri,%20Stephanie&rft.date=2009-07-01&rft.volume=21&rft.issue=3&rft.spage=140&rft.epage=142&rft.pages=140-142&rft.issn=0966-3274&rft.eissn=1878-5492&rft_id=info:doi/10.1016/j.trim.2009.04.002&rft_dat=%3Cproquest_cross%3E67332058%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67332058&rft_id=info:pmid/19386281&rft_els_id=1_s2_0_S0966327409000379&rfr_iscdi=true